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Abstract:
Light-induced retinal degeneration (LIRD) causes photoreceptor cell death in albino mice
after exposure to high intensity light for a set period of time (6-24 hours). This causes retinal
photoreceptor cell death through apoptosis. From several previous studies, Dr. Mandal’s lab
concluded that de novo biosynthesis of ceramide mediates photoreceptor cell death in a LIRD
model. Previous studies in Dr. Mandal’s lab has shown that mouse models with higher
endogenous ω-3 Polyunsaturated Fatty Acids (n-3 PUFA) generates less ceramide upon neuronal
injury and prevent neurodegeneration (Mol Neurobio 2021). There are currently not many
available effective therapies for retinal degeneration in humans that have inherited diseases
leading to blindness. We speculate that higher endogenous n-3 PUFA will prevent retinal
degeneration in mouse model of light induced retinal degeneration.
This project aimed to see a significant difference between LD-Control vs LD-PUFA.
Results showed that there was a significant difference between NLD-Control vs LD-Control and
NLD-PUFA vs LD-PUFA. Similar levels of degeneration of retinal photoreceptors occurred in
n-3 PUFA and control. n-3 PUFA has shown inconclusive results for decreasing photoreceptor
cell death. Further testing should be done to confirm the significance of the effect of n-3 PUFA
in a mouse-model.
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1 Introduction:
Light-induced retinal degeneration (LIRD) causes photoreceptor cell death in albino mice
after exposure to high intensity light for a set period of time (6-24 hours). This causes retinal
photoreceptor cell death through apoptosis. Retinal cell death through apoptosis caused by LIRD
is similar to retinal degeneration in humans.1 The close similarity between the retinal
degeneration of the albino mice and humans have sparked extensive studies of the mechanism
behind the retinal photoreceptor death. From several previous studies, Dr. Mandal’s lab
concluded that de novo biosynthesis of ceramide mediates photoreceptor cell death in a LIRD
model.2 Ceramide is a sphingolipid that can be produced through many different pathways and
act as a second messenger in retinal cell death. The main pathway of ceramide production in
retinal cells are orchestrated by serine palmitoyl transferase. Other pathways use
sphingomyelinase to convert sphingomyelin to ceramide, and another pathway hydrolyzes
complex sphingolipids such as cerebrosides and gangliosides, until it eventually forms ceramide.
The last pathway to consider is the salvage pathway which utilizes recycled sphingosine to
produce ceramide.
Previous studies in Dr. Mandal’s lab has shown that mouse models with higher
endogenous ω-3 Polyunsaturated Fatty Acids (n-3 PUFA) generates less ceramide upon neuronal
injury and prevent neurodegeneration (Mol Neurobio 2021). Previous studies have shown that
members of the n-3 PUFA family, docosahexaenoic acid (DHA) and eicosapentaenoic acid
(EPA), have potential therapeutic effects since they play a role in controlling inflammatory
pathways.6, 14-16 We speculate that higher endogenous n-3 PUFA will prevent retinal
degeneration in mouse model of light induced retinal degeneration.
Hypothesis:
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Enrichment of ω-3 Polyunsaturated Fatty Acids (n-3 PUFA) in the retina of a mouse
model will protect the retina from light induced retinal degeneration (LIRD), preventing acute
damage to the retina.
Significance:
There are currently not many available effective therapies for retinal degeneration in
humans that have inherited diseases leading to blindness. Analyzing potential compounds that
could be used in the development for a therapeutic strategy could potentially slow down or
prevent retinal degeneration. We identified that sphingolipid ceramide is a potential second
messenger for retinal degeneration. There are available drugs such as fumonisin B1, myriocin,
and FTY720. However, these drugs have systemic effects which are unfavorable. 2,3 n-3 PUFA
can be used as a potential therapeutic, as well as a natural supplement as an augmentative
therapy with potentially fewer side effects.
2 Methods
Animals:
Albino Blabc mice will be involved in this project. The experiments performed will
follow the protocol approved by UTHSC’s Institutional Animal Care and Use Committee.
Diet of Animals:
Groups of WT C57BL/6 mice will be fed an ω-3 Polyunsaturated Fatty Acids (n-3
PUFA)-enriched diet from birth. These diets will be prepared from Dyets Incorporation by
supplementing AIN-93G purified rodent diet with n-3 PUFA, 20% lipids supplied by EPA and
DHA (2:1 EPA:DHA ratio), which is commercially available in liquid form (Dr. Sears’
OmegaRx 2 Fish Oil Liquid from Zone Labs Inc., Peabody, MA 01960). Groups of WT mice fed
with the control diet (AIN-93G) will serve as controls for the n-3 PUFA group.
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Light Induced Retinal Degeneration (LIRD) and Data collection:
Adult (2 months +) albino mice on the ω-3 Polyunsaturated Fatty Acids (n-3 PUFA)enriched diet and the control animals will be born and raised in a dim light room (5-10 lux) and
exposed to 1,500 lux white light for 6 hours to induce LIRD. Unexposed mice from both the
groups will serve as controls. Mice will be transferred to their native dim room and retinal
function will be tested using electroretinography after 7 days.
Electroretinography (ERG):
Electroretinography allows us to analyze the function of the rod and cone photoreceptors after
albino mice are exposed to light as described in previously published studies. Mice were dark
adapted overnight and were prepared for ERG under dim red light. They were anesthetized with
ketamine (100mg/kg) and xylazine (5mg/kg) body eight via intraperitoneal (IP) injection. For
dilation of the pupil, a drop of 1% (w/v) Atropine and 1% (w/v) Tropicamide (Akorn Inc., Lake
Forest, IL) along with a drop of 0.5% (w/v) Proparacaine HCl (Alkon Lab, Fort Worth, TX) as
local anesthetics were applied on the cornea. Throughout the whole procedure, a heating pad at
37°C was used to keep the mice warm and maintain their body temperature. For ERG
measurement, a designated gold electrode was placed on the cornea, a reference electrode was
positioned on the head, a ground electrode was placed at the tail, and the mouse was placed in a
Ganzfeld illuminating sphere. For scotopic ERG, three strobe flash stimuli were presented at
flash intensities of 0.1, 1, and 10 cd.s/m 2. The amplitude of the a-wave was measured from the
pre-stimulus baseline to the a-wave trough. The amplitude of the b-wave was measured from the
trough of the a-wave to the peak of the b-wave.
Histology:
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After recording data with electroretinography, the histology of the albino mice’s retina can be
analyzed by following a procedure done in Dr. Mandal’s lab. The eyes can be harvested and cut
along the vertical meridian through the optic nerve into five micron-thick sections. The cut
sections can be analyzed microscopically after staining the sections with hematoxylin and eosin.
Biochemical assays of the retinas from independent groups of animals harvested at 0 hours and 6
hours after exposure to light from the treated and control groups will be conducted by lipidomics,
qRT-PCR, and Western blotting.
Results:

4 groups of Balb/c albino mice with n=3 in each separated into Non-light damage (NLDControl), Light damage (LD-Control), Non-light damage-PUFA (NLD-PUFA), Light damagePUFA (LD-PUFA). Mice were exposed at 3 different intensity levels: 0.1, 1, and 10 cd.s/m2.
Statistical significance was found to be between NLD-Control vs LD-Control and NLD-PUFA
vs LD-PUFA.
Discussion:
Results showed that there was a significant difference between NLD-Control vs LD-Control and
NLD-PUFA vs LD-PUFA. This project aimed to see a significant difference between LDControl vs LD-PUFA. However, there was not a statistical significance even though prior
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research has strongly suggested that n-3 PUFA should have a systemic effect on the
inflammatory pathway which should include the retina. A possible reason for not seeing any
statistical significance could have been that the project only had n=3 for the results.
Unfortunately, biological experiments can run into many barriers, postponing results. Our other
experiments to increase the number of n ran into an error that led to growing another group of
Balb/c albino mice for future experiments 2-3 months into the future. Once these experiments are
done, it is possible that there may be statistical significance between the LD-control vs LDPUFA groups.
Conclusion:
Similar levels of degeneration of retinal photoreceptors occurred in n-3 PUFA and control. n-3
PUFA has shown inconclusive results for decreasing photoreceptor cell death. Further testing
should be done to confirm the significance of the affect of n-3 PUFA in a mouse-model.
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